Workshop Main Page | Program Purpose | Faculty | Presentation Slides & Schedule 
Published Documents | Friend of the President | Photos
October 28, 2009
Gaylord National Hotel and Convention Center
Washington, D.C.
Program Schedule
To view slides from a presenter, click the icon next to their name.
Wednesday, October 28 |
|
| 7:45 am - 7:50 am | Welcome and Introduction Bernard A. Fox, PhD - Earle A. Chiles Research Institute |
| 7:50 am - 8:00 am | Biomarkers and the Critical Pathway Initiative Samir Khleif, MD - National Cancer Institute |
| 8:00 am - 8:15 am | FDA Perspective on Biomarkers Steven Kozlowski, MD - Food and Drug Administration, Office of Biotechnology Products |
| 8:15 am - 8:25 am | The Biomarkers Consortium: A Public-Private Partnership to Advance Biomarker Research Shawnmarie Mayrand-Chung, PhD, JD - National Institutes of Health - Office of the Director, OPSA Public-Private Partnerships Program |
| 8:25 am - 10:30 am | Session 1: Standardization and Validation of Immunologic Biomarkers Co-Chairs: Mary (Nora) Disis, MD - University of Washington Sylvia Janetzki, MD - ZellNet Consulting |
| 8:25 am - 8:55 am | Standardization of Immune Biomarkers: Lessons from the HIV Field Alan L. Landay, PhD - Rush University Medical Center |
| 8:55 am - 9:15 am | Immune Monitoring Consortium Experience Mary (Nora) Disis, MD - University of Washington |
| 9:15 am - 9:25 am | Multi-Institution Trials and the Eastern Cooperative Oncology Group Lisa H. Butterfield, PhD - University of Pittsburgh |
| 9:25 am - 10:30 am | Discussion Moderator: Sylvia Janetzki, MD - ZellNet ConsultingDiscussants: Cedrik Britten, MD - Johannes Gutenberg University Dominic Eisinger, PhD - Rules Based Medicine, Inc. |
| 10:30 am - 10:50 am | Break |
| 10:50 am - 12:50 pm | Session 2: Determining Potency of Immunologic Therapy Co-Chairs: A. Karolina Palucka, MD, PhD - Baylor Institute for Immunology Research Theresa Whiteside, PhD - University of Pittsburgh Cancer Institute |
| 10:50 am - 11:10 am | Assessing Dendritic Cell Vaccines A. Karolina Palucka, MD, PhD - Baylor Institute for Immunology Research |
| 11:10 am - 11:30 am | Mechanisms of Immune Suppression and Regulatory T Cells Theresa Whiteside, PhD - University of Pittsburgh Cancer Institute |
| 11:30 am - 11:50 am | Use of Molecular Assays to Assess Cellular Therapies David Stroncek, MD - Cell Processing, DTM, CC, National Institutes of Health |
| 11:50 am - 12:50 pm | Discussion Moderator: Licia Rivoltini, MD - Fondazione IRCCS Istituto Nazionale dei Tumori Discussant: Edwin Walker, PhD - Providence Cancer Center |
| 12:50 pm - 1:20 pm | Lunch |
| 1:20 pm - 3:20 pm | Session 3: Assessing the Immunologic Signature of Clinical Response Co-Chairs: Cedrik M. Britten, MD - Johannes Gutenberg University Vernon C. Maino, PhD - BD Biosciences |
| 1:20 pm - 1:40 pm | T Cell Response Signatures in Breast Cancer vs. Chronic Infection Holden T. Maecker, PhD - Stanford University Medical Center |
| 1:40 pm - 2:00 pm | Immunity to Glycolipid and Stem Cell Antigens in Human Cancer Madhav Dhodapkar, MD - Yale University |
| 2:00 pm - 2:20 pm | Summary of the US-Japan Workshop on Immunotherapy Markers in Oncology Hideaki Tahara, MD, PhD - University of Tokyo |
| 2:20 pm - 3:20 pm | Discussion Moderator: Lupe G. Salazar, MD - University of Washington Discussant: Keith Bahjat, PhD - Earle A. Chiles Research Institute |
| 3:20 pm - 3:45 pm | Break |
| 3:45 pm - 4:45 pm | Session 4: Centralization of Immunologic Monitoring Co-Chairs: Alan L. Landay, PhD - Rush University Medical Center Anatoli M. Malyguine, MD, PhD - SAIC-Frederick, NCI-Frederick |
| 3:45 pm - 3:55 pm | Immunologic Monitoring of Cancer Vaccine Trials - What to Measure, How and Why? Anatoli M. Malyguine, MD, PhD - SAIC-Frederick, NCI-Frederick |
| 3:55 pm - 4:25 pm | System Biology Approaches Rafick-Pierre Sékaly, PhD - University of Montreal, VGTI Florida |
| 4:25 pm - 4:45 pm | Some Statistical Issues in the Design and Analysis of Vaccine Clinical Trials in Cancer Patients Douglas M. Potter, PhD - University of Pittsburgh |
| 4:45 pm - 7:00 pm | Session 5: Novel Marker Identification Co-Chairs: Peter P. Lee, MD - Stanford University Francesco Marincola, MD - National Institutes of Health |
| 4:45 pm - 5:00 pm | High Throughput Technology and Predictive Immune Monitoring Peter P. Lee, MD - Stanford University |
| 5:00 pm - 5:20 pm | Systems Immunology at the Bedside Damien Chaussabel, PhD - Baylor Institute for Immunology Research |
| 5:20 pm - 5:40 pm | Trans-NIH Center for Human Immunology: Goals and Progress Giorgio Trinchieri, MD - National Cancer Institute |
| 5:40 pm - 6:20 pm | Application of Proteomics to Biomarker Discovery: New Challenges, New Technology Lance Liotta, MD, PhD - George Mason University |
| 6:20 pm - 7:00 pm | Defining Immunologic Health Mark M. Davis, PhD - Howard Hughes Medical Institute / Stanford University School of Medicine |
| 7:00 pm | Networking Reception |
All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
